Sujing Xu Selected Research

schizandrin A

5/2022	Corrigendum to "Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway" [Biomed. Pharmacother. 115 (2019) 108922].
7/2019	Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sujing Xu Research Topics

Disease

2	Triple Negative Breast Neoplasms 05/2022 - 07/2019
2	Kidney Diseases (Kidney Disease) 01/2019 - 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Obesity 01/2019
1	Fibrosis (Cirrhosis) 01/2019

Drug/Important Bio-Agent (IBA)

2	schizandrin AIBA 05/2022 - 07/2019
2	Toll-Like Receptor 4IBA 01/2019 - 01/2019
1	Angiotensin IIIBA 01/2019
1	NSC 74859IBA 01/2019